TFX — Teleflex Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Annual income statement for Teleflex, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,537	2,810	2,791	2,974	3,047
Cost of Revenue
Gross Profit	1,325	1,550	1,531	1,647	1,703
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	2,114	2,194	2,292	2,468	2,896
Operating Profit	423	615	499	506	151
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	358	559	446	434	75.5
Provision for Income Taxes
Net Income After Taxes	336	485	363	358	70.2
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	335	485	363	356	69.7
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	335	485	363	356	69.7
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	8.59	9.2	7.92	8.54	9.28
Dividends per Share